Anticancer properties of novel 4-methylene-1,2-diphenylpyrazolidin-3-ones
- PMID: 25832885
- DOI: 10.1111/cbdd.12565
Anticancer properties of novel 4-methylene-1,2-diphenylpyrazolidin-3-ones
Abstract
The limited success of the currently used antitumor therapies is the driving force for organic chemists to seek new lead structures with anticancer potential. Two α-methylene-γ-lactams with an additional nitrogen atom in the lactam ring, 5-vinyl-1,2-diphenyl-4-methylenepyrazolidin-3-one (2a) and 5-phenyl-1,2-diphenyl-4-methylenepyrazolidin-3-one (2b) have been synthesized. Their anticancer activity was assessed in MCF-7 cells. Both compounds inhibited cell proliferation and induced DNA damage and apoptosis, with 2a being the more potent analog. Synergistic effects of 2a used in combination with known anticancer drugs, 5-fluorouracil, taxol, and oxaliplatin were evaluated. Compound 2a significantly enhanced the antitumor action of oxaliplatin and 5-fluorouracil, but not taxol.
Keywords: DNA damage; anticancer drugs; apoptosis; breast cancer; cell proliferation; α-Methylene-γ-lactams.
© 2015 John Wiley & Sons A/S.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
